Composition for preventing or treating sleep disorders comprising Massa Medicata Fermentata and Maydis stigma extracts
A composition of Massa Medicata Fermentata and Maydis stigma extracts addresses the limitations of current sleep disorder treatments by reducing sleep onset time and increasing duration, offering a safe and effective solution for sleep disorders.
Patent Information
- Application Number
- KR1020230008630
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-01-20
- Publication Date
- 2026-08-03
- Estimated Expiration
- 2043-01-20
AI Technical Summary
Current treatments for sleep disorders, including both pharmacological and natural remedies, face limitations in efficacy, safety, and market growth due to uncertainties regarding their effects and mechanisms, and there is a high demand for low-dependence, low-side-effect sleep aids.
A pharmaceutical, quasi-drug, or food composition comprising extracts of Massa Medicata Fermentata (Shenqu) and Maydis stigma (Yumichuxu) as active ingredients, which are extracted using water or organic solvents, to reduce sleep onset time and increase sleep duration by increasing melatonin receptor expression.
The composition effectively reduces sleep onset time and increases sleep duration, with no toxicity or side effects, and can be used safely for long-term treatment of sleep disorders related to anxiety, stress, aging, and neurological diseases.